Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
US8114989B2 · kind B2 · utility
65Cited by
34References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2010 |
| Grant date | Feb 14, 2012 |
| Priority date | — |
| Expiry date | Feb 26, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds having the formula (I):and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.